Design of protein delivery systems by mimicking extracellular mechanisms for protection of growth factors. (November 2017)

• Record Type: Journal Article
• Authors: Silva, Carla; Carretero, Agatha; Soares da Costa, Diana; Reis, Rui L.; Novoa-Carballal, Ramon; Pashkuleva, Iva
• Is Part Of: Acta biomaterialia. Volume 63(2017)
• Page Start: 283
• Page End: 293
• Publication Date: 2017-11
• Subjects: Heparin -- Oxime click reaction -- Polyelectrolyte complexation -- FGF-2 -- Delivery system; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1016/j.actbio.2017.08.042
• Languages: English
• ISSNs: 1742-7061

Abstract

Graphical abstract: Abstract: Heparin sulfate proteoglycans (HSPGs) are responsible for the storage and stabilization of numerous growth factors in the extracellular matrix. In this complex native environment, the efficient binding of the growth factors is determined by multivalent, specific and reversible electrostatic interactions between the sulfate groups of HSPGs and the positively charged amino acids of the growth factor. Inspired by this naturally occurring stabilization process, we propose the use of diblock copolymers of heparin and polyethylene glycol (Hep- b -PEG) for protection and delivery of FGF-2. We describe the encapsulation of FGF-2 into spontaneously assembling polyelectrolyte complexes (PECs) with Hep- b -PEG in which the Hep block ensures the formation of the PECs, while the PEG moiety confers stability of the generated complex by a stealth corona. Our results demonstrate that by this method we can generate homogeneous complexes (ca. 400 nm diameter, PDI 0.29 ± 0.07) with a very high encapsulation efficiency (about 99% encapsulated FGF-2). The release of the growth factor in response to different stimuli such as pH, ionic strength or presence of heparinase was also studied. We report a sustained release of up to 80% during 28 days which is not influenced by the presence of heparinase – a result that clearly demonstrates the protective effect of the stealth corona. We also show that FGF-2 remains bioactive as it influences the morphology of bone marrow mesenchymal stem cells. Statement of Significance: We describe a biopolymer that uses the way the cells shield a type of proteins (growth factors) to simultaneously assemble, slowly deliver and shield the protein in a "nanocarrier". Growth factors are essential for the regeneration of cartilage, bones by stem cell therapies but have a short life time as when added directly to tissues. Our design makes use of the heparin bioactivity towards such proteins in combination with a polyethylene glycol moiety (PEG) that makes a protecting shell. PEG, is biocompatible and used in approved medicines and countless cosmetic products. The highest novelty is the reaction (oxime click) used to bound these molecules that does not require modification of heparin and allows preservation of its bioactivity.